In situ cancer vaccination using lipidoid nanoparticles

In situ vaccination is a promising strategy for cancer immunotherapy owing to its convenience and the ability to induce numerous tumor antigens. However, the advancement of in situ vaccination techniques has been hindered by low cross-presentation of tumor antigens and the immunosuppressive tumor mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jinjin, Qiu, Min, Ye, Zhongfeng, Nyalile, Thomas, Li, Yamin, Glass, Zachary, Zhao, Xuewei, Yang, Liu, Chen, Jianzhu, Xu, Qiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099179/
https://www.ncbi.nlm.nih.gov/pubmed/33952519
http://dx.doi.org/10.1126/sciadv.abf1244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099179/
https://www.ncbi.nlm.nih.gov/pubmed/33952519
http://dx.doi.org/10.1126/sciadv.abf1244

Ejemplares similares